谱系追踪与单细胞分析揭示肝癌进展中增殖性Prom1+肿瘤 propagating 细胞及其动态细胞转变
该研究利用两种小鼠HCC模型(慢性纤维化型和快速脂肪变性相关型),通过Prom1谱系追踪和靶向清除,结合单细胞RNA测序,发现Prom1在HCC中标记具有CSC样特性的增殖性肿瘤 propagating 细胞,这些细胞在原发性肿瘤中原位克隆扩增,清除Prom1+细胞可抑制肿瘤生长并减少恶性特征,scRNA-seq揭示Prom1+ HCC细胞异质性及向高增殖和干细胞特性的去分化轨迹,保守基因签名预测人HCC不良预后。
要点
- Prom1标记HCC中具有CSC样特性的增殖性肿瘤 propagating 细胞。
- 清除Prom1+细胞可抑制两种HCC模型的肿瘤生长和恶性特征。
- Prom1谱系保守基因签名预测人HCC不良预后。
核心结论
- Prom1在HCC中标记增殖性肿瘤 propagating 细胞,具有CSC样特性,其异质性和动态转变促进肝癌进展。
研究设计与样本
- 建立两种小鼠模型分别代表慢性纤维化HCC和快速脂肪变性相关HCC。
- 使用Prom1C-L/+; Rosa26tdTomato/+小鼠进行谱系追踪,Prom1C-L/+; Rosa26DTA/+小鼠进行靶向清除。
- 对追踪的Prom1+细胞进行单细胞RNA测序分析转录组谱。
主要发现
- 谱系追踪显示Prom1+细胞在原发性肿瘤中原位克隆扩增。
- 标记的Prom1+细胞在3D培养和同种异体移植中致瘤性增加,移植后可形成不同谱系癌症。
- 清除Prom1+细胞阻碍两种HCC模型的肿瘤生长并减少恶性癌症标志。
- scRNA-seq揭示Prom1+ HCC细胞异质性,遵循向高增殖和干细胞特性去分化状态的轨迹。
- Prom1谱系保守基因签名预测人HCC不良预后,激活的氧化解毒是去分化转变和谱系传播的保护机制。
临床怎么用
- Prom1+细胞可作为HCC治疗的潜在靶点,清除这些细胞可能抑制肿瘤生长。
- Prom1谱系基因签名可用于预测HCC患者预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hepatocellular carcinoma (HCC) has high intratumoral heterogeneity, which contributes to therapeutic resistance and tumour recurrence. We previously identified Prominin-1 (PROM1)/CD133 as an important liver cancer stem cell (CSC) marker in human HCC. The aim of this study was to investigate the heterogeneity and properties of Prom1+ cells in HCC in intact mouse models. DESIGN: We established two mouse models representing chronic fibrotic HCC and rapid steatosis-related HCC. We performed lineage tracing post-HCC induction using Prom1C-L/+; Rosa26tdTomato/+ mice, and targeted depletion using Prom1C-L/+; Rosa26DTA/+ mice. Single-cell RNA sequencing (scRNA-seq) was carried out to analyse the transcriptomic profile of traced Prom1+ cells. RESULTS: Prom1 in HCC tumours marks proliferative tumour-propagating cells with CSC-like properties. Lineage tracing demonstrated that these cells display clonal expansion in situ in primary tumours. Labelled Prom1+ cells exhibit increasing tumourigenicity in 3D culture and allotransplantation, as well as potential to form cancers of differential lineages on transplantation. Depletion of Prom1+ cells impedes tumour growth and reduces malignant cancer hallmarks in both HCC models. scRNA-seq analysis highlighted the heterogeneity of Prom1+ HCC cells, which follow a trajectory to the dedifferentiated status with high proliferation and stem cells traits. Conserved gene signature of Prom1 linage predicts poor prognosis in human HCC. The activated oxidant detoxification underlies the protective mechanism of dedifferentiated transition and lineage propagation. CONCLUSION: Our study combines in vivo lineage tracing and scRNA-seq to reveal the heterogeneity and dynamics of Prom1+ HCC cells, providing insights into the mechanistic role of malignant CSC-like cells in HCC progression.
引用
- Zhou L, Yu KH, Wong TL, et al. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut. 2021. PMID: 34588223. doi:10.1136/gutjnl-2021-324321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。